40% topline growth offset by margin miss; recovery hinges on LPG normalization
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 6/10
Grade B
Revenue beat 15% FY26 guidance (delivered 40.5%). PAT growth (27% YoY) tracking FY26–27 20% 2-year target. Margin guidance (24-25%) clearly missed; recovery is management assertion, not locked.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Q1 delivered strong 40.5% YoY revenue and 27% PAT growth against a solid ₹2,329 Cr order book, but EBITDA margin collapsed to 19.4% vs 24-25% prior guidance—a ~500 bps miss attributed to LPG crisis and raw material volatility. Management expects recovery from Q3, but the sequential 78.9% PAT decline and fixed-price defense contract exposure create near-term downside risk if commodity headwinds persist.
₹239.5 Cr
Revenue · +40.5% YoY₹16.5 Cr
Reported PAT · +27% YoYCompressing
Margins · vs guidance: MixedDid the claims hold up?
Turnover Rs. 239.49 Cr, growth 40.46% YoY
METDelivered Rs. 239.5 Cr revenue, 40.5% YoY growth
Profit after tax increased 27.42% to Rs. 16.31 Cr
METDelivered Rs. 16.5 Cr PAT, 27.0% YoY growth
EBITDA margins expected 24%-25% (prior guidance)
OVERSTATEDQ1 EBITDA ₹46.6 Cr / ₹239.5 Cr revenue = 19.4% margin
Margins will normalize to 20-21% from Q3 onwards
PartialBelow prior 24-25% guidance; predicated on LPG/RM normalization unconfirmed
Order book Rs. 2,329 Cr as of July 1, 2026
UnverifiedStated on call, consistent with defense-heavy portfolio (66% defense)
Earnings quality
What changed since the last call
Margin outlook softer
DowngradePrior 24-25% EBITDA guidance now expected at ~20-21% from Q3 as LPG/RM headwinds persist into H2. No recovery to 24%+ stated.
Revenue growth narrative intact
Neutral40.5% YoY beat 15% FY26 guidance easily. But 40% run-rate non-sustainable per management. Full-year growth still expected better than FY26, not quantified precisely.
Order book composition shifted
NeutralDefense now 66% (vs space-heavy historical mix). Titanium ₹600 Cr subset. Shift reflects defense sector strength but increases customer concentration risk on fixed-price contracts.
Capex approval timeline vague
New₹1,000 Cr 3-year capex for modernization now in ministry evaluation. No timeline provided; FY27 capex remains ₹50-60 Cr maintenance-only. Major uncertainty on execution.
The Q&A
Analysts pressed hard on margin recovery credibility, 40% growth sustainability, and capex timing. Management hedged on all three. CFO candid that margin recovery is 'hope' for Q3, not certainty. Directors clarified 40% not annual run-rate; capex approval timeline opaque. Overall: rigorous Q&A; management held ground but did not commit to specific recovery numbers.
Margin compression drivers — Ajinkya Jadhav, KRIIS Portfolio
AnsweredLPG prices doubled (war crisis), major factor. Also raw material prices elevated. Q2 may see continued hit; Q3 normalization expected.
40% growth sustainability — Abhishek Jain, KRIIS PMS
Partial40% at quarter level not practicable for year. FY27 growth will be better than FY26. Margin improvement expected H2, driven by mix and cost normalization.
Capex and asset turn — Abhishek Jain, KRIIS PMS
DodgedCapex has long lead time. Projects to realize after 4-5 years stabilization. Difficult to quantify near-term asset turn now.
Titanium order book upside — Abhishek Jain, KRIIS PMS
Partial₹600 Cr order book exists. Titanium margins higher than special steel. Will increase contribution. Challenges: processing time, material availability.
S400 certification TAM — Sheetal Shah, Individual Investor
AnsweredCertification enables testing for all materials. Revenue depends on customer uptake. Very conservatively estimating 10% incremental revenue. Will know in 2-3 quarters.
Capex ministry approval timeline — Sheetal Shah, Individual Investor
DodgedFormal process underway. Cannot commit timeline. Will update shareholders once approved.
Metal bank working capital impact — Renjith Sivaram, Mahindra Manulife MF
AnsweredNo impact on MIDHANI books; customer-owned, MIDHANI-operated. Just storing material for melting.
Scrap titanium inventory liquidation — Renjith Sivaram, Mahindra Manulife MF
AnsweredScrap is 'gold mine' for melting; integral to process. Optimally managed. Sell when exceeds threshold. Last year reduced ₹75 Cr scrap inventory.
Nomination order erosion — Ajinkya Jadhav, KRIIS Portfolio
AnsweredCorrect. No nomination orders now; all competitive bidding.
Global OEM timeline — Ajinkya Jadhav, KRIIS Portfolio
AnsweredCertification in progress. Within ~1 year should get approvals. Multiple audits and modifications underway.
Guidance
FY27 growth better than FY26; 40% Q1 not sustainable
MediumQ1 beat 15% FY26 guidance easily at 40.5%. Management clarified 40% not annual run-rate. Implies ~20-30% FY27 growth estimate, not quantified.
Export revenue target 10% baseline, scale 15-20% annually
MediumCurrent ₹33 Cr exports on implied ₹600-700 Cr FY27 revenue = ~5% penetration. Target ₹100-120 Cr exports (15-20% growth) over 3-4 years via S400 cert and OEM approvals.
EBITDA margin recovery to ~20-21% from Q3 onwards
LowPrior 24-25% guidance now tacitly abandoned. Management 'hopes' Q3 normalization on LPG/RM relief. Q1 at 19.4%; Q2 'may be little bit hit'; Q3+ recovery. No commitment to 24%+ recovery.
Titanium and super alloy margins higher than steel
HighMix shift toward titanium (₹600 Cr order book) and super alloy expected to support margin accretion mid-term, contingent on product mix execution.
₹1,000 Cr capex over 3 years (modernization, downstream efficiency)
LowProposal pending ministry evaluation. No timeline. FY27 capex remains ₹50-60 Cr maintenance-only. Results visible year 4-5 post-completion.
Metal bank secured materials procurement 2Q FY27 end
MediumOne customer in advanced stage; pilots underway. Full rollout timeline vague. Does not impact balance sheet (customer-owned).
Risks the call surfaced
Raw material & energy price volatility
HighQ1 experienced ₹14 Cr adverse RM price variance (nickel, moly, tungsten, cobalt) and ₹5 Cr LPG crisis impact on margins. Fixed-price defense contracts prevent cost pass-through. Metal bank pilot only in stage for 1 customer.
Customer concentration & order lumpiness
MediumDefense 66% of ₹2,329 Cr order book. Sequential revenue down 56.7% QoQ, PAT down 78.9% QoQ. Small-cap aerospace supplier model inherently lumpy. Program delays (AMCA approval) could defer order ramp.
Margin compression and competitive intensity
HighEBITDA margin 19.4% vs 24-25% prior guidance—500+ bps miss. Shift from nomination-based (higher margin) to competitive bidding (lower margin) eroding profitability. Fixed-price exposure absorbs commodity shocks.
Capex execution & ministry approval
Medium₹1,000 Cr modernization capex (3 years) pending ministry evaluation. No timeline provided. If delayed/denied, productivity gains deferred. FY27 capex remains ₹50-60 Cr maintenance-only. Capex results visible year 4-5.
Global OEM qualification timeline
MediumRolls-Royce, Boeing, Airbus certifications in progress; management expects ~1 year to approval. No guarantees. S400 cert from GE opens path but Nadcap and OEM audits are rigorous. Titanium sponge imports from East Europe subject to geopolitical/sanctions risk.
Management
Score 7/10. Candid on challenges (LPG crisis, RM volatility, margin compression, nomination order loss). Transparent on limitations (capex timeline unknown, S400 revenue 'probably 2-3 quarters later'). Some hedging on recovery timing ('hope' for Q3 normalization) and capex approval (cannot commit). Revenue track record solid: beat 15% FY26 guidance with 40.5%. PAT growth 27% tracking 20% 2-year target. Margin delivery weak: 19.4% vs 24-25% guidance (-550 bps miss). Scrap inventory management effective (₹75 Cr reduction). Certifications on track (S400 done, Nadcap by end-FY27).
1 · Q2 FY27
Metal bank operational for customer; LPG crisis stabilization
2 · Q3 FY27
Margin normalization expected; Nadcap certification close
3 · FY27 end
S400, ISO 27001, ISO 50001 certifications; bulletproof jacket trials complete
Management expects recovery from Q3, but the sequential 78.9% PAT decline and fixed-price defense contract exposure create near-term downside risk if commodity headwinds persist.
Informational and educational content only. Not investment advice.